TGFB1 and neoplasm: TGFβ is dysregulated in many types of cancer and acts both as a tumor suppressor at early stages of tumor development (by inhibiting proliferation and inducing apoptosis) and as a tumor promoter at late stages (by inducing EMT or by suppressing immune responses against the tumor) (19).